Exploration of more personalized treatments in ovarian cancer using a pharmacodynamic protein biomarker and patient-derived xenograft technology
(2020)
- Author
- Elien De Thaye
- Promoter
- Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Pieter Colin (UGent)
- Organization
Downloads
-
PhD .pdf
- full text (Published version)
- |
- open access
- |
- |
- 56.39 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8680336
- MLA
- De Thaye, Elien. Exploration of More Personalized Treatments in Ovarian Cancer Using a Pharmacodynamic Protein Biomarker and Patient-Derived Xenograft Technology. Universiteit Gent. Faculteit Farmaceutische Wetenschappen, 2020.
- APA
- De Thaye, E. (2020). Exploration of more personalized treatments in ovarian cancer using a pharmacodynamic protein biomarker and patient-derived xenograft technology. Universiteit Gent. Faculteit Farmaceutische Wetenschappen.
- Chicago author-date
- De Thaye, Elien. 2020. “Exploration of More Personalized Treatments in Ovarian Cancer Using a Pharmacodynamic Protein Biomarker and Patient-Derived Xenograft Technology.” Universiteit Gent. Faculteit Farmaceutische Wetenschappen.
- Chicago author-date (all authors)
- De Thaye, Elien. 2020. “Exploration of More Personalized Treatments in Ovarian Cancer Using a Pharmacodynamic Protein Biomarker and Patient-Derived Xenograft Technology.” Universiteit Gent. Faculteit Farmaceutische Wetenschappen.
- Vancouver
- 1.De Thaye E. Exploration of more personalized treatments in ovarian cancer using a pharmacodynamic protein biomarker and patient-derived xenograft technology. Universiteit Gent. Faculteit Farmaceutische Wetenschappen; 2020.
- IEEE
- [1]E. De Thaye, “Exploration of more personalized treatments in ovarian cancer using a pharmacodynamic protein biomarker and patient-derived xenograft technology,” Universiteit Gent. Faculteit Farmaceutische Wetenschappen, 2020.
@phdthesis{8680336, author = {{De Thaye, Elien}}, language = {{eng}}, pages = {{xii, 143}}, publisher = {{Universiteit Gent. Faculteit Farmaceutische Wetenschappen}}, school = {{Ghent University}}, title = {{Exploration of more personalized treatments in ovarian cancer using a pharmacodynamic protein biomarker and patient-derived xenograft technology}}, year = {{2020}}, }